Patrick Truesdell
Keine laufenden Positionen mehr
Vermögen: - $ am 30.04.2024
Ursprung des Netzwerks ersten Grades von Patrick Truesdell
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 6 | |
| Extinct | Biotechnology | 5 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Patrick Truesdell
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| REGENERON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| ALEXION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Davidson Kempner Capital Management LP
 Davidson Kempner Capital Management LP Investment ManagersFinance Davidson Kempner Capital Management LLC (DKCM) is an independent, SEC-registered investment advisor and hedge fund management firm headquartered in New York City. The firm was founded in 1983 by Marvin Davidson and Thomas Kempner Sr. DKCM provides investment advice and investment management services to private investment funds. | Investment Managers | Corporate Officer/Principal | |
Liberty Mutual Insurance Co.
 Liberty Mutual Insurance Co. Property/Casualty InsuranceFinance Liberty Mutual Insurance Co. provides auto, home and life insurance services. The firm offers insurance for personal automobile, workers compensation, homeowners, commercial multiple peril, commercial automobile, general liability, global specialty, group disability, assumed reinsurance, fire and surety. The company was founded on July 1, 1912 and is headquartered in Boston, MA. | Property/Casualty Insurance | Corporate Officer/Principal | |
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| ARENA PHARMACEUTICALS | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Memgen, Inc.
 Memgen, Inc. Pharmaceuticals: MajorHealth Technology Memgen, Inc. operates as a clinical-stage biotech company. Its product ISF35, is a viral cancer immunotherapy encoding an optimized version of CD40 ligand. The company was founded by Robert C. Coates and is headquartered in Houston, TX. | Pharmaceuticals: Major | Director/Board Member | |
| Sackler School of Medicine | College/University | Doctorate Degree | |
| ACHILLION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| SUCAMPO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| ORCHARD THERAPEUTICS PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
| University of Maryland | College/University | Undergraduate Degree | |
| The Fuqua School of Business | College/University | Masters Business Admin | |
Gemini Therapeutics Sub, Inc.
 Gemini Therapeutics Sub, Inc. BiotechnologyHealth Technology Gemini Therapeutics Sub, Inc. engages in the development of treatments for age-related macular degeneration (AMD) and linked ocular disorders. Its multimodal pipeline includes monoclonal antibodies, recombinant proteins and gene therapies. The company was founded by James McLaughlin, Johanna Seddon, Paul Barlow and Andrew Herbert in 2015 and is headquartered in Cambridge, MA. | Biotechnology | Chief Executive Officer | |
Vtesse, Inc.
 Vtesse, Inc. BiotechnologyHealth Technology Vtesse, Inc. provides novel drugs for life-threatening rare diseases. It developed VTS-270, a modified form of cyclodextrin that has been evaluated in preclinical and clinical studies at institutes within the National Institutes of Health (NIH) to treat patients with Niemann-Pick Disease Type C (NPC). The firm is working with the NIH and other leading academic centers to advance clinical study of VTS-270 for NPC, and to conduct pre-clinical discovery and development of other novel drugs for NPC and other LSDs. The company was founded by Ben Machielse in 2015 and is headquartered in Gaithersburg, MD. | Biotechnology | Corporate Officer/Principal | |
| Alexion Pharma GmbH | Corporate Officer/Principal | ||
| University of West Florida | College/University | Graduate Degree | |
| Babson College | College/University | Masters Business Admin | |
| INTELLIA THERAPEUTICS, INC. | Biotechnology | Corporate Officer/Principal | |
| McGill University | College/University | Undergraduate Degree | |
| Columbia University Vagelos College of Physicians & Surgeons | College/University | Doctorate Degree | |
| SONA NANOTECH INC. | Chemicals: Specialty | Director/Board Member | |
| University of Campania Luigi Vanvitelli | College/University | Doctorate Degree | |
| University of Surrey | College/University | Graduate Degree | |
| Old Dominion University | College/University | Undergraduate Degree | |
| OREXIGEN THERAPEUTICS, INC. | Pharmaceuticals: Major | Comptroller/Controller/Auditor | |
RTW Investments LP
 RTW Investments LP Investment ManagersFinance RTW Investments LP (RTW) is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded by Dr. Roderick Wong in 2010. RTW provides discretionary advisory services to various RTW Funds. | Investment Managers | Chief Executive Officer | |
| University of London | College/University | Doctorate Degree | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Undergraduate Degree | |
| ROCKET PHARMACEUTICALS, INC. | Biotechnology | Chairman | |
Attune Pharmaceuticals, Inc.
 Attune Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Attune Pharmaceuticals, Inc. engages in the provision of biotechnology services. It discovers and develops orally-administered small-molecule therapeutics for the treatment of rare diseases. The company was founded by Andrew Ian McDonald and is headquartered in New York, NY. | Miscellaneous Commercial Services | Director/Board Member | |
| Harvard Business School | College/University | Masters Business Admin | |
| Perelman School of Medicine | College/University | Doctorate Degree | |
| AVIDITY BIOSCIENCES, INC. | Biotechnology | Director/Board Member | |
RTW Investments /Venture/
 RTW Investments /Venture/ Investment ManagersFinance RTW Investments /Venture/ (RTW Investments) is a venture capital subsidiary of RTW Investments LP founded in 2009 by Roderick Wong. The firm is headquartered in New York. | Investment Managers | Chief Investment Officer | |
NiKang Therapeutics, Inc.
 NiKang Therapeutics, Inc. BiotechnologyHealth Technology NiKang Therapeutics, Inc. operates as biotechnology company. It focuses on developing novel small molecule oncology drug discovery. The company was founded by Zhenhai Gao and is headquartered in Wilmington, DE. | Biotechnology | Director/Board Member | |
Jixing Pharmaceutical Technology (Shanghai) Co. Ltd.
 Jixing Pharmaceutical Technology (Shanghai) Co. Ltd. Pharmaceuticals: MajorHealth Technology Jixing Pharmaceutical Technology (Shanghai) Co. Ltd. is a Chinese company that develops and commercializes novel therapeutics. Yan Ping Mou has been the CEO of the company since 2023. | Pharmaceuticals: Major | Director/Board Member | |
Rocket Pharmaceuticals Ltd.
 Rocket Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Rocket Pharmaceuticals Ltd. operates as a biotechnology company which focuses on developing gene therapy treatment for undertreated diseases. The firm’s pipeline includes Fanconi Anemia, Pyruvate Kinase Deficiency, Leukocyte Adhesion Deficiency-1 and Infantile Malignant Osteopetrosis. It also develops an AAV-based therapy program for an undisclosed rare pediatric disease. The company is headquartered in New York, NY. | Pharmaceuticals: Major | Chairman | |
| AMAG PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Warp Drive Bio, Inc.
 Warp Drive Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Warp Drive Bio, Inc. focused on proprietary genomic technology to discover drugs of natural origin. The firm deployed proprietary platforms Genome Mining and Small Molecule Assisted Receptor Targeting (SMART) to discover and develop novel molecules addressing new pharmacologic mechanisms. The company was founded by Gregory L. Verdine, George McDonald Church, and James A. Wells in 2012 and was headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| NUVASIVE, INC. | Medical Specialties | Comptroller/Controller/Auditor |
Statistik
International
| Vereinigte Staaten | 37 |
| Vereinigtes Königreich | 4 |
| Schweiz | 3 |
| Kanada | 3 |
| Israel | 2 |
Sektoral
| Health Technology | 23 |
| Consumer Services | 15 |
| Finance | 6 |
| Commercial Services | 4 |
| Process Industries | 2 |
Operativ
| Corporate Officer/Principal | 29 |
| Director/Board Member | 14 |
| Chief Tech/Sci/R&D Officer | 8 |
| Chief Executive Officer | 7 |
| Undergraduate Degree | 6 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Rod Wong | 15 |
| Gregory Oakes | 12 |
| Jason Meyenburg | 9 |
| Patricia Bitar | 8 |
| Walter Strapps | 7 |
| Alka Batycky | 6 |
| Avner Ingerman | 6 |
| Fabio Cataldi | 5 |
| Precillia Redmond | 4 |
| Claudia Lopez | 4 |
| Marissa Volpe | 1 |
- Börse
- Insiders
- Patrick Truesdell
- Unternehmensverbindungen
